Literature DB >> 17701342

International study of health care organization and financing: development of renal replacement therapy in Germany.

Werner Kleophas1, Helmut Reichel.   

Abstract

The German health system represents the case of a global budget with negotiated fees and competing medical insurance companies. Physicians in private practice and non-profit dialysis provider associations provide most dialysis therapy. End-stage renal disease (ESRD) modalities are well integrated into the overall health care system. Dialysis therapy, independent of the mode of treatment, is reimbursed at a weekly flat rate. Mandatory health insurance covers health expenses, including those related to ESRD, for more than 90% of the population. Both employees and employers contribute to the premium for this insurance. Private medical insurance covers the remainder of the population. Access to treatment, including dialysis therapy, is uniformly available.

Entities:  

Mesh:

Year:  2007        PMID: 17701342     DOI: 10.1007/s10754-007-9020-0

Source DB:  PubMed          Journal:  Int J Health Care Finance Econ        ISSN: 1389-6563


  13 in total

1.  Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States.

Authors:  Allan J Collins; Bertram Kasiske; Charles Herzog; Blanche Chavers; Robert Foley; David Gilbertson; Richard Grimm; Jiannong Liu; Thomas Louis; Willard Manning; Arthur Matas; Marshall McBean; Anne Murray; Wendy St Peter; Jay Xue; Qiao Fan; Haifeng Guo; Shuling Li; Suying Li; Tricia Roberts; Jon Snyder; Craig Solid; Changchun Wang; Eric Weinhandl; Cheryl Arko; Shu-Cheng Chen; Frederick Dalleska; Frank Daniels; Stephan Dunning; James Ebben; Eric Frazier; Roger Johnson; Daniel Sheets; Beth Forrest; Delaney Berrini; Edward Constantini; Susan Everson; Pamela Frederick; Paul Eggers; Lawrence Agodoa
Journal:  Am J Kidney Dis       Date:  2005-01       Impact factor: 8.860

Review 2.  End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF).

Authors:  Avi Dor; Mark V Pauly; Margaret A Eichleay; Philip J Held
Journal:  Int J Health Care Finance Econ       Date:  2007-09

3.  International Study of Health Care Organization and Financing of renal services in England and Wales.

Authors:  Tricia Nicholson; Paul Roderick
Journal:  Int J Health Care Finance Econ       Date:  2007-12

4.  The financing and organization of medical care for patients with end-stage renal disease in Sweden.

Authors:  Björn Wikström; Michael Fored; Margaret A Eichleay; Stefan H Jacobson
Journal:  Int J Health Care Finance Econ       Date:  2007-12

Review 5.  International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality.

Authors:  Giuseppe Pontoriero; Pietro Pozzoni; Lucia Del Vecchio; Francesco Locatelli
Journal:  Int J Health Care Finance Econ       Date:  2007-09

6.  The organization and financing of dialysis and kidney transplantation services in New Zealand.

Authors:  Toni Ashton; Mark Roger Marshall
Journal:  Int J Health Care Finance Econ       Date:  2007-12

7.  Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Ronald L Pisoni; Jennifer L Bragg-Gresham; Eric W Young; Tadao Akizawa; Yasushi Asano; Francesco Locatelli; Juergen Bommer; Jose Miguel Cruz; Peter G Kerr; David C Mendelssohn; Philip J Held; Friedrich K Port
Journal:  Am J Kidney Dis       Date:  2004-07       Impact factor: 8.860

Review 8.  Belgium's mixed private/public health care system and its impact on the cost of end-stage renal disease.

Authors:  Wim Van Biesen; Norbert Lameire; Patrick Peeters; Raymond Vanholder
Journal:  Int J Health Care Finance Econ       Date:  2007-09

9.  The organization and financing of end-stage renal disease in Spain.

Authors:  José Luño
Journal:  Int J Health Care Finance Econ       Date:  2007-12

10.  The organization and financing of kidney dialysis and transplant care in the United States of America.

Authors:  Richard A Hirth
Journal:  Int J Health Care Finance Econ       Date:  2007-12
View more
  13 in total

Review 1.  End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF).

Authors:  Avi Dor; Mark V Pauly; Margaret A Eichleay; Philip J Held
Journal:  Int J Health Care Finance Econ       Date:  2007-09

2.  International Study of Health Care Organization and Financing of renal services in England and Wales.

Authors:  Tricia Nicholson; Paul Roderick
Journal:  Int J Health Care Finance Econ       Date:  2007-12

3.  Dialysis: Choice of dialysis--what to do with economic incentives.

Authors:  Kai Ming Chow; Philip Kam-Tao Li
Journal:  Nat Rev Nephrol       Date:  2012-07-31       Impact factor: 28.314

Review 4.  Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.

Authors:  Raymond Vanholder; Lieven Annemans; Edwina Brown; Ron Gansevoort; Judith J Gout-Zwart; Norbert Lameire; Rachael L Morton; Rainer Oberbauer; Maarten J Postma; Marcello Tonelli; Wim Van Biesen; Carmine Zoccali
Journal:  Nat Rev Nephrol       Date:  2017-05-30       Impact factor: 28.314

5.  Epidemiology of glomerulonephritis in Northern Germany.

Authors:  Norbert Braun; Anna Schweisfurth; Christine Lohöfener; Catalina Lange; Christian Gründemann; Günther Kundt; Hermann-Josef Gröne
Journal:  Int Urol Nephrol       Date:  2011-04-20       Impact factor: 2.370

6.  The financing and organization of medical care for patients with end-stage renal disease in Sweden.

Authors:  Björn Wikström; Michael Fored; Margaret A Eichleay; Stefan H Jacobson
Journal:  Int J Health Care Finance Econ       Date:  2007-12

Review 7.  International Study of Health Care Organization and Financing for end-stage renal disease in France.

Authors:  Isabelle Durand-Zaleski; Christian Combe; Philippe Lang
Journal:  Int J Health Care Finance Econ       Date:  2007-09

Review 8.  Belgium's mixed private/public health care system and its impact on the cost of end-stage renal disease.

Authors:  Wim Van Biesen; Norbert Lameire; Patrick Peeters; Raymond Vanholder
Journal:  Int J Health Care Finance Econ       Date:  2007-09

9.  International Comparisons to Assess Effects of Payment and Regulatory Changes in the United States on Anemia Practice in Patients on Hemodialysis: The Dialysis Outcomes and Practice Patterns Study.

Authors:  Douglas S Fuller; Brian A Bieber; Ronald L Pisoni; Yun Li; Hal Morgenstern; Tadao Akizawa; Stefan H Jacobson; Francesco Locatelli; Friedrich K Port; Bruce M Robinson
Journal:  J Am Soc Nephrol       Date:  2015-11-18       Impact factor: 10.121

10.  Implementation of a quality and safety checklist for haemodialysis sessions.

Authors:  Daniele Marcelli; Antero Matos; Francisco Sousa; Ricardo Peralta; João Fazendeiro; Angel Porra; Victor Moscardo; Maria Teresa Parisotto; Andrea Stopper; Bernard Canaud
Journal:  Clin Kidney J       Date:  2015-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.